ESC 365 - PCSK9 Inhibitors: deep dive into guidelines and clinical data

ESC Premium Access

PCSK9 Inhibitors: deep dive into guidelines and clinical data

Session: Understanding PCSK9 Inhibitors: what, when and why?

Topic: PCSK9-Antagonists

Speaker: Associate Professor K. Kostner (Brisbane, AU)

Sponsored by Amgen

Event: ESC Asia with APSC & AFC

Congress Presentation

Add to my library

About the speaker

Associate Professor Karam Kostner

University of Queensland, Brisbane (Australia)

1 presentation

0 follower

3 more presentations in this session

Welcome and opening remarks: confronting the burden of LDL-C in Asia

Speaker: Associate Professor J. Tan (Singapore, SG)

Treating patients in the real world

Speaker: Professor S. Uemura (Kurashiki, JP)

Questions and answers and closing remarks

Speaker: Associate Professor J. Tan (Singapore, SG)

Access the full session

Understanding PCSK9 Inhibitors: what, when and why?

Speakers: Associate Professor K. Kostner, Associate Professor J. Tan, Professor S. Uemura, Associate Professor J. Tan

About the event

ESC Asia with APSC & AFC

8 November - 10 November 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources